Genetic screening for HLA-B*57, including the B*57:01 allele associated with an increased risk of abacavir hypersensitivity
The genetic screening test detects a version of one of the genesów (called the B*57:01 allele) thatóra associated with hypersensitivity to the drug abacavir, in order to select a treatment strategy.

Synevo
- Test description
- Documents
Genetic screening test for HLA-B*57, including the B*57:01 allele associated with an increased risk of hypersensitivity to abacavir
Clinical purpose
Genetic screening test for HLA-B*57, including the B*57:01 allele associated with an increased risk of hypersensitivity to abacavir, an antiviral drug used to treat HIV infection. The test is performed before starting abacavir treatment because of the increased risk of hypersensitivity to the drug in patientsów who carry the allele.
Patient Preparation
Material: EDTA blood